Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein polypeptide G pseudogene 18 (SNRPGP18) is a human pseudogene; it is a DNA sequence that resembles the functional SNRPG gene but contains mutations or alterations that prevent it from being correctly transcribed and/or translated into a functional protein[1][3][5]. Pseudogenes such as SNRPGP18 are classified as nonfunctional genomic elements—they may arise via gene duplication or retrotransposition, leading to lost or altered coding potential, and do not produce functional proteins[5]. SNRPGP18 is not considered a therapeutic target, and there are no known drugs, biological functions, or disease roles specifically associated with this locus. There is no evidence for its use as a biomarker or its involvement in the mechanism of action of any therapeutics. Its principal relevance is in genomic studies as a representative pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide G pseudogene 18 (SNRPGP18).